{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:45:00Z","timestamp":1785321900647,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:00:00Z","timestamp":1795046400000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007412","name":"Nippon Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ama221231h0002"],"award-info":[{"award-number":["JP25ama221231h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ck0106795h0003"],"award-info":[{"award-number":["JP25ck0106795h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["25ama221242h0001"],"award-info":[{"award-number":["25ama221242h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ama221210h0003"],"award-info":[{"award-number":["JP24ama221210h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K18383"],"award-info":[{"award-number":["JP22K18383"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K02333"],"award-info":[{"award-number":["JP24K02333"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.lungcan.2025.108833","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:26:15Z","timestamp":1762597575000},"page":"108833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tumor heterogeneity involving SCLC with a single exon deletion in RB1 and adenocarcinoma with EGFR-L718V mutation in EGFR-TKI\u2013resistant lung cancer"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8482-5548","authenticated-orcid":false,"given":"Sho","family":"Kakuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Uchibori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6837-6392","authenticated-orcid":false,"given":"Eisaku","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatoshi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7394-895X","authenticated-orcid":false,"given":"Ryohei","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2025.108833_b0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1289\/ehp.1408626","article-title":"Global analysis of posttranscriptional gene expression in response to sodium arsenite","volume":"123","author":"Qiu","year":"2015","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.lungcan.2025.108833_b0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jtho.2021.11.020","article-title":"Lung Cancer in Japan","volume":"17","author":"Horinouchi","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2025.108833_b0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40291-021-00563-1","article-title":"Worldwide prevalence of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysis","volume":"26","author":"Melosky","year":"2021","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.lungcan.2025.108833_b0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2022.04.002","article-title":"EGFR signaling pathway as therapeutic target in human cancers","volume":"85","author":"Levantini","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lungcan.2025.108833_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133164","article-title":"Targeting the epidermal growth factor receptor in egfr-mutated lung cancer: current and emerging therapies","volume":"13","author":"Khaddour","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lungcan.2025.108833_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3263-z","article-title":"Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A","volume":"17","author":"Chiba","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2025.108833_b0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2009.11.022","article-title":"Preexistence and Clonal selection of MET Amplification in EGFR Mutant NSCLC","volume":"17","author":"Turke","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2025.108833_b0040","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1158\/2159-8290.CD-12-0108","article-title":"HER2 amplification: a potential mechanism of acquired resistance to egfr inhibition in EGFR -mutant lung cancers that lack the second-site EGFR T790M mutation","volume":"2","author":"Takezawa","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.lungcan.2025.108833_b0045","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41392-024-01981-3","article-title":"Mechanism exploration and model construction for small cell transformation in EGFR-mutant lung adenocarcinomas","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lungcan.2025.108833_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.869390","article-title":"Comparison of T790M Acquisition after Treatment with First- and Second-Generation Tyrosine-Kinase Inhibitors: a Systematic Review and Network Meta-Analysis","volume":"12","author":"Hsieh","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lungcan.2025.108833_b0055","doi-asserted-by":"crossref","unstructured":"C.-H. Yun, K.E. Mengwasser, A. V Toms, M.S. Woo, H. Greulich, K.-K. Wong, M. Meyerson, M.J. Eck, The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP, 2007. www.pnas.org\/cgi\/content\/full\/.","DOI":"10.1073\/pnas.0709662105"},{"key":"10.1016\/j.lungcan.2025.108833_b0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa1612674","article-title":"Osimertinib or Platinum\u2013Pemetrexed in EGFR T790M\u2013Positive Lung Cancer","volume":"376","author":"Mok","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108833_b0065","article-title":"Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer","volume":"14","author":"Chmielecki","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2025.108833_b0070","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/j.jtho.2016.05.019","article-title":"L718Q mutation as new mechanism of acquired resistance to AZD9291 in EGFR-mutated NSCLC","volume":"11","author":"Bersanelli","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2025.108833_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2018.01.015","article-title":"Acquired EGFR L718V mutation mediates resistance to osimertinib in non-small cell lung cancer but retains sensitivity to afatinib","volume":"118","author":"Liu","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2025.108833_b0080","article-title":"Rare case of de novo EGFR L718V mutation-positive non-small cell lung cancer successfully treated with afatinib","volume":"10","author":"Ito","year":"2023","journal-title":"Curr. Prob. Cancer: Case Reports"},{"key":"10.1016\/j.lungcan.2025.108833_b0085","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/j.jtho.2019.07.018","article-title":"Acquired EGFR L718V Mutation and loss of T790M-mediated Resistance to Osimertinib in a Patient with NSCLC who Responded to Afatinib","volume":"14","author":"Fang","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2025.108833_b0090","first-page":"1","article-title":"A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer","volume":"8","author":"Suzuki","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.lungcan.2025.108833_b0095","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241280689","article-title":"BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer","volume":"16","author":"Lim","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.lungcan.2025.108833_b0100","doi-asserted-by":"crossref","unstructured":"S. Fukuda, K. Suda, A. Hamada, H. Oiki, S. Ohara, M. Ito, J. Soh, T. Mitsudomi, Y. Tsutani, Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms\u2014An In Vitro Study, Biomedicines 2024, Vol. 12, Page 1412 12 (2024) 1412. https:\/\/doi.org\/10.3390\/BIOMEDICINES12071412.","DOI":"10.3390\/biomedicines12071412"},{"key":"10.1016\/j.lungcan.2025.108833_b0105","article-title":"Nervous system contributions to small cell lung cancer: Lessons from diverse oncological studies, Biochimica et Biophysica Acta (BBA) - Reviews on","volume":"1880","author":"Liao","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2025.108833_b0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2025.108833_b0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jncc.2021.11.001","article-title":"Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas","volume":"1","author":"Zhong","year":"2021","journal-title":"Journal of the National Cancer Center"},{"key":"10.1016\/j.lungcan.2025.108833_b0120","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1073\/pnas.0436813100","article-title":"Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation","volume":"100","author":"Xiao","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lungcan.2025.108833_b0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jcp.25053","article-title":"Error-prone repair of DNA double-strand breaks","volume":"231","author":"Rodgers","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lungcan.2025.108833_b0130","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1073\/pnas.1213431110","article-title":"Microhomology-mediated End joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells","volume":"110","author":"Truong","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225007251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225007251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:07:25Z","timestamp":1777518445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225007251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":26,"alternative-id":["S0169500225007251"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108833","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor heterogeneity involving SCLC with a single exon deletion in RB1 and adenocarcinoma with EGFR-L718V mutation in EGFR-TKI\u2013resistant lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108833"}}